Drug Shortage Report for MYLAN-VERAPAMIL SR

Last updated on 2020-12-01 History
Report ID 121246
Drug Identification Number 02450496
Brand name MYLAN-VERAPAMIL SR
Common or Proper name VERAPAMIL
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) VERAPAMIL HYDROCHLORIDE
Strength(s) 240MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100BT, 500BT
ATC code C08DA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-11-25
Actual start date 2020-11-25
Estimated end date 2021-01-12
Actual end date 2020-11-30
Shortage status Resolved
Updated date 2020-12-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v31 2020-12-01 English Compare
v30 2020-11-30 French Compare
v29 2020-11-30 English Compare
v28 2020-11-25 English Compare
v27 2020-11-10 French Compare
v26 2020-11-10 English Compare
v25 2020-11-05 English Compare
v24 2020-11-03 French Compare
v23 2020-11-03 English Compare
v22 2020-10-20 French Compare
v21 2020-10-20 English Compare
v20 2020-10-14 French Compare
v19 2020-10-14 English Compare
v18 2020-10-14 French Compare
v17 2020-10-14 English Compare
v16 2020-09-30 French Compare
v15 2020-09-30 English Compare
v14 2020-09-22 French Compare
v13 2020-09-22 English Compare
v12 2020-09-14 French Compare

Showing 1 to 20 of 31